CSF2 and cancer: One of the most important advantages of DNA cancer vaccines is the possibility of flexible design of plasmids with multiple tumor antigens and incorporation of immunomodulatory genes (such as interleukins including IL-1 or GM-CSF and Toll-like receptor (TLR) agonists) (18).